Scopus Biopharma, Inc. v. Hopper et al
Plaintiff: Scopus Biopharma, Inc.
Defendant: Paul Hopper, Ashish Sanghrajka and Kilinwata Investments Pty, Ltd.
Case Number: 1:2021cv08165
Filed: October 3, 2021
Court: US District Court for the Southern District of New York
Presiding Judge: Alison J Nathan
Nature of Suit: Securities/Commodities
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on January 18, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
January 18, 2022 Filing 14 NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, without prejudice against the defendant(s) Paul Hopper, Kilinwata Investments Pty, Ltd., Ashish Sanghrajka. Document filed by Scopus Biopharma, Inc.. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Skinner, Peter)
November 10, 2021 Opinion or Order Filing 13 ORDER: This case has been assigned to me for all purposes. It is hereby ORDERED that counsel for all parties appear for an initial pretrial conference with the Court on Friday, January 28, 2022 at 3:15 pm. IT IS FURTHER ORDERED parties are to submit their Proposed Civil Case Management Plan and Joint Letter, as directed below, no later than Wednesday, January 19, 2022. Unless the Court states otherwise, the Court will not hold the upcoming initial pretrialconference in this case in person. The conference will proceed by telephone. The parties and members of the public may access the conference by dialing (888) 363-4749 and entering access code 9196964. Counsel should review and comply with the Court's Emergency Individual Rules and Practices in Light of COVID-19, available at https://www.nysd.uscourts.gov/hon-alison-j-nathan. Included with the Proposed Civil Case Management Plan, the parties shall submit a Joint Letter, not to exceed five (5) pages, providing the following information in separate paragraphs: as set forth herein. SO ORDERED. Initial Conference set for 1/28/2022 at 03:15 PM before Judge Alison J. Nathan. (Signed by Judge Alison J. Nathan on 11/09/2021) (ama)
October 4, 2021 Filing 12 ELECTRONIC SUMMONS ISSUED as to Kilinwata Investments Pty, Ltd. (vf)
October 4, 2021 Filing 11 ELECTRONIC SUMMONS ISSUED as to Ashish Sanghrajka. (vf)
October 4, 2021 Filing 10 ELECTRONIC SUMMONS ISSUED as to Paul Hopper. (vf)
October 4, 2021 Filing 9 CIVIL COVER SHEET filed..(Skinner, Peter)
October 4, 2021 Filing 8 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Scopus Biopharma, Inc...(Skinner, Peter)
October 4, 2021 Filing 7 NOTICE OF APPEARANCE by Joanna Christine Wright on behalf of Scopus Biopharma, Inc...(Wright, Joanna)
October 4, 2021 Case Designated ECF. (vf)
October 4, 2021 CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Alison J. Nathan. Please download and review the Individual Practices of the assigned District Judge, located at #https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #https://nysd.uscourts.gov/rules/ecf-related-instructions..(vf)
October 4, 2021 Magistrate Judge Katharine H. Parker is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (vf)
October 4, 2021 ***NOTICE TO ATTORNEY REGARDING CIVIL. CASE OPENING STATISTICAL ERROR CORRECTION: Notice to attorney Peter M. Skinner. The following case opening statistical information was erroneously selected/entered: Cause of Action code 28:1331sv Fed. Question: Securities Violation; Nature of Suit code 370 (Other Fraud). The following correction(s) have been made to your case entry: the Cause of Action code has been modified to 15:78m(a) Securities Exchange Act; the Nature of Suit code has been modified to 850 (Securities/Commodities). (vf)
October 4, 2021 ***NOTICE TO ATTORNEY REGARDING DEFICIENT CIVIL COVER SHEET. Notice to attorney Peter M. Skinner to RE-FILE Document No. #2 Civil Cover Sheet. The filing is deficient for the following reason(s): Nature of Suit Error; Multiple Nature of Suits were selected on Form. Place an [x] one box only. PDF Error; the 2nd page of form is not provided. Re-file the document using the event type Civil Cover Sheet found under the event list Other Documents and attach the correct PDF. Use civil cover sheet issued by S.D.N.Y. dated October 1, 2020. The S.D.N.Y. Civil Cover Sheet dated October 1, 2020 is located at#http://nysd.uscourts.gov/file/forms/civil-cover-sheet. (vf)
October 3, 2021 Filing 6 NOTICE OF APPEARANCE by Peter M. Skinner on behalf of Scopus Biopharma, Inc...(Skinner, Peter)
October 3, 2021 Filing 5 REQUEST FOR ISSUANCE OF SUMMONS as to Kilinwata Investments Pty, Ltd., re: #1 Complaint,. Document filed by Scopus Biopharma, Inc...(Skinner, Peter)
October 3, 2021 Filing 4 REQUEST FOR ISSUANCE OF SUMMONS as to Ashish Sanghrajka, re: #1 Complaint,. Document filed by Scopus Biopharma, Inc...(Skinner, Peter)
October 3, 2021 Filing 3 REQUEST FOR ISSUANCE OF SUMMONS as to Paul Hopper, re: #1 Complaint,. Document filed by Scopus Biopharma, Inc...(Skinner, Peter)
October 3, 2021 Filing 2 FILING ERROR - PDF ERROR - CIVIL COVER SHEET filed..(Skinner, Peter) Modified on 10/4/2021 (vf).
October 3, 2021 Filing 1 COMPLAINT against Paul Hopper, Kilinwata Investments Pty, Ltd., Ashish Sanghrajka. (Filing Fee $ 402.00, Receipt Number ANYSDC-25143122)Document filed by Scopus Biopharma, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11).(Skinner, Peter)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System

Search for this case: Scopus Biopharma, Inc. v. Hopper et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Scopus Biopharma, Inc.
Represented By: Joanna Christine Wright
Represented By: Peter M. Skinner
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Paul Hopper
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ashish Sanghrajka
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Kilinwata Investments Pty, Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?